Clinical utility of exemestane in the treatment of breast cancer

Breast cancer is the most prevalent cancer in women, causing a significant mortality worldwide. Different endocrine strategies are available for the treatment of hormone-sensitive breast cancer, including antiestrogen tamoxifen and fulvestrant, as well as third-generation aromatase inhibitors (AIs),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zucchini, Giorgia, Geuna, Elena, Milani, Andrea, Aversa, Caterina, Martinello, Rossella, Montemurro, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455847/
https://www.ncbi.nlm.nih.gov/pubmed/26064072
http://dx.doi.org/10.2147/IJWH.S69475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455847/
https://www.ncbi.nlm.nih.gov/pubmed/26064072
http://dx.doi.org/10.2147/IJWH.S69475

Ejemplares similares